Skip to content

Effects of chewing nicotine gum on pain control and recovery of bowel function after laparoscopic gynecologic surgery

Effects of chewing nicotine gum on pain control and recovery of bowel function after laparoscopic gynecologic surgery

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002528
Enrollment
Unknown
Registered
2012-09-21
Start date
2013-01-31
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative analesia and postoperative recovery of bowel function

Interventions

control:controventional postoperative care regimen
G:sugarless gum
GN:sugarless gum

Sponsors

West China Second University Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: All subjects aged 18~50 yr, scheduled to undergo advanced elective laparoscopic gynecological procedures; All patients were American Society of Anesthesiologists (ASA) physical status I or II.

Exclusion criteria

Exclusion criteria: Exclusion criteria were current or recent smoking history within the last 6 mo, a history of uncontrolled hypertension, ischemic heart disease, arrhythmias, stroke, respiratory disease, peptic ulcer disease, peritoneal carcinomatosis, inflammatory bowel disease, previous gastric or esophageal surgery (due to vagus nerve injury), or gut motility influencing agents (for example, tricyclic antidepressants), pregnancy, chronic pain, drug or alcohol abuse, or use of chronic pain medications, the use of spinal or epidural anesthesia during the operation, and known allergy to and of the study medications. Patients were excluded if there was a history of psychiatric disorder. Patients receiving regular opioids or drugs with known analgesic properties in the 24 h before surgery were also excluded. Furthermore, patients with disturbance of acetylcholine metabolism in any way, such as neurological disease, medication (SSRI), or depression were excluded.

Design outcomes

Primary

MeasureTime frame
visual analogue score;

Secondary

MeasureTime frame
time to first flatus;time to first defecation;the incidence of nause during the first 12 hours after surgery;the incidence of vomiting during the first 12 hours after surgery;the blood pressure during 12 hours after surgery;the heart rate during 12 hours after surgery;the requirement of analgesics during the first 6 hours/12 hours/24 hours after surgery;the requirement of antiemetic during the first 6 hours/12 hours/24 hours after surgery;the amounts of pro-inflammatory factors(TNF-a/IL-1b/IL-6) in patients plasma;the length of hospital stay;

Countries

China

Contacts

Public ContactHua Feng Li
lihuafeng2005@hotmail.com+86 13558808877

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026